table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Biopharmaceutical Third Party Logistics Market Size Analysis from 2022 to 2027
1.5.1 Global Biopharmaceutical Third Party Logistics Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Biopharmaceutical Third Party Logistics Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Biopharmaceutical Third Party Logistics Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Biopharmaceutical Third Party Logistics Industry Impact
Chapter 2 Global Biopharmaceutical Third Party Logistics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biopharmaceutical Third Party Logistics (Volume and Value) by Type
2.1.1 Global Biopharmaceutical Third Party Logistics Consumption and Market Share by Type (2016-2021)
2.1.2 Global Biopharmaceutical Third Party Logistics Revenue and Market Share by Type (2016-2021)
2.2 Global Biopharmaceutical Third Party Logistics (Volume and Value) by Application
2.2.1 Global Biopharmaceutical Third Party Logistics Consumption and Market Share by Application (2016-2021)
2.2.2 Global Biopharmaceutical Third Party Logistics Revenue and Market Share by Application (2016-2021)
2.3 Global Biopharmaceutical Third Party Logistics (Volume and Value) by Regions
2.3.1 Global Biopharmaceutical Third Party Logistics Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Biopharmaceutical Third Party Logistics Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Biopharmaceutical Third Party Logistics Consumption by Regions (2016-2021)
4.2 North America Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
4.10 South America Biopharmaceutical Third Party Logistics Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Biopharmaceutical Third Party Logistics Market Analysis
5.1 North America Biopharmaceutical Third Party Logistics Consumption and Value Analysis
5.1.1 North America Biopharmaceutical Third Party Logistics Market Under COVID-19
5.2 North America Biopharmaceutical Third Party Logistics Consumption Volume by Types
5.3 North America Biopharmaceutical Third Party Logistics Consumption Structure by Application
5.4 North America Biopharmaceutical Third Party Logistics Consumption by Top Countries
5.4.1 United States Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
5.4.2 Canada Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
5.4.3 Mexico Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 6 East Asia Biopharmaceutical Third Party Logistics Market Analysis
6.1 East Asia Biopharmaceutical Third Party Logistics Consumption and Value Analysis
6.1.1 East Asia Biopharmaceutical Third Party Logistics Market Under COVID-19
6.2 East Asia Biopharmaceutical Third Party Logistics Consumption Volume by Types
6.3 East Asia Biopharmaceutical Third Party Logistics Consumption Structure by Application
6.4 East Asia Biopharmaceutical Third Party Logistics Consumption by Top Countries
6.4.1 China Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
6.4.2 Japan Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
6.4.3 South Korea Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 7 Europe Biopharmaceutical Third Party Logistics Market Analysis
7.1 Europe Biopharmaceutical Third Party Logistics Consumption and Value Analysis
7.1.1 Europe Biopharmaceutical Third Party Logistics Market Under COVID-19
7.2 Europe Biopharmaceutical Third Party Logistics Consumption Volume by Types
7.3 Europe Biopharmaceutical Third Party Logistics Consumption Structure by Application
7.4 Europe Biopharmaceutical Third Party Logistics Consumption by Top Countries
7.4.1 Germany Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.2 UK Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.3 France Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.4 Italy Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.5 Russia Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.6 Spain Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.7 Netherlands Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.8 Switzerland Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
7.4.9 Poland Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 8 South Asia Biopharmaceutical Third Party Logistics Market Analysis
8.1 South Asia Biopharmaceutical Third Party Logistics Consumption and Value Analysis
8.1.1 South Asia Biopharmaceutical Third Party Logistics Market Under COVID-19
8.2 South Asia Biopharmaceutical Third Party Logistics Consumption Volume by Types
8.3 South Asia Biopharmaceutical Third Party Logistics Consumption Structure by Application
8.4 South Asia Biopharmaceutical Third Party Logistics Consumption by Top Countries
8.4.1 India Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
8.4.2 Pakistan Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Biopharmaceutical Third Party Logistics Market Analysis
9.1 Southeast Asia Biopharmaceutical Third Party Logistics Consumption and Value Analysis
9.1.1 Southeast Asia Biopharmaceutical Third Party Logistics Market Under COVID-19
9.2 Southeast Asia Biopharmaceutical Third Party Logistics Consumption Volume by Types
9.3 Southeast Asia Biopharmaceutical Third Party Logistics Consumption Structure by Application
9.4 Southeast Asia Biopharmaceutical Third Party Logistics Consumption by Top Countries
9.4.1 Indonesia Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
9.4.2 Thailand Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
9.4.3 Singapore Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
9.4.4 Malaysia Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
9.4.5 Philippines Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
9.4.6 Vietnam Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
9.4.7 Myanmar Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 10 Middle East Biopharmaceutical Third Party Logistics Market Analysis
10.1 Middle East Biopharmaceutical Third Party Logistics Consumption and Value Analysis
10.1.1 Middle East Biopharmaceutical Third Party Logistics Market Under COVID-19
10.2 Middle East Biopharmaceutical Third Party Logistics Consumption Volume by Types
10.3 Middle East Biopharmaceutical Third Party Logistics Consumption Structure by Application
10.4 Middle East Biopharmaceutical Third Party Logistics Consumption by Top Countries
10.4.1 Turkey Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.3 Iran Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.5 Israel Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.6 Iraq Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.7 Qatar Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.8 Kuwait Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
10.4.9 Oman Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 11 Africa Biopharmaceutical Third Party Logistics Market Analysis
11.1 Africa Biopharmaceutical Third Party Logistics Consumption and Value Analysis
11.1.1 Africa Biopharmaceutical Third Party Logistics Market Under COVID-19
11.2 Africa Biopharmaceutical Third Party Logistics Consumption Volume by Types
11.3 Africa Biopharmaceutical Third Party Logistics Consumption Structure by Application
11.4 Africa Biopharmaceutical Third Party Logistics Consumption by Top Countries
11.4.1 Nigeria Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
11.4.2 South Africa Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
11.4.3 Egypt Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
11.4.4 Algeria Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
11.4.5 Morocco Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 12 Oceania Biopharmaceutical Third Party Logistics Market Analysis
12.1 Oceania Biopharmaceutical Third Party Logistics Consumption and Value Analysis
12.2 Oceania Biopharmaceutical Third Party Logistics Consumption Volume by Types
12.3 Oceania Biopharmaceutical Third Party Logistics Consumption Structure by Application
12.4 Oceania Biopharmaceutical Third Party Logistics Consumption by Top Countries
12.4.1 Australia Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
12.4.2 New Zealand Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 13 South America Biopharmaceutical Third Party Logistics Market Analysis
13.1 South America Biopharmaceutical Third Party Logistics Consumption and Value Analysis
13.1.1 South America Biopharmaceutical Third Party Logistics Market Under COVID-19
13.2 South America Biopharmaceutical Third Party Logistics Consumption Volume by Types
13.3 South America Biopharmaceutical Third Party Logistics Consumption Structure by Application
13.4 South America Biopharmaceutical Third Party Logistics Consumption Volume by Major Countries
13.4.1 Brazil Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
13.4.2 Argentina Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
13.4.3 Columbia Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
13.4.4 Chile Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
13.4.5 Venezuela Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
13.4.6 Peru Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
13.4.8 Ecuador Biopharmaceutical Third Party Logistics Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Biopharmaceutical Third Party Logistics Business
14.1 DHL
14.1.1 DHL Company Profile
14.1.2 DHL Biopharmaceutical Third Party Logistics Product Specification
14.1.3 DHL Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Kuehne + Nagel
14.2.1 Kuehne + Nagel Company Profile
14.2.2 Kuehne + Nagel Biopharmaceutical Third Party Logistics Product Specification
14.2.3 Kuehne + Nagel Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 DB Schenker Logistics
14.3.1 DB Schenker Logistics Company Profile
14.3.2 DB Schenker Logistics Biopharmaceutical Third Party Logistics Product Specification
14.3.3 DB Schenker Logistics Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Nippon Express
14.4.1 Nippon Express Company Profile
14.4.2 Nippon Express Biopharmaceutical Third Party Logistics Product Specification
14.4.3 Nippon Express Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 C.H. Robinson Worldwide
14.5.1 C.H. Robinson Worldwide Company Profile
14.5.2 C.H. Robinson Worldwide Biopharmaceutical Third Party Logistics Product Specification
14.5.3 C.H. Robinson Worldwide Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 UPS Supply Chain Solutions
14.6.1 UPS Supply Chain Solutions Company Profile
14.6.2 UPS Supply Chain Solutions Biopharmaceutical Third Party Logistics Product Specification
14.6.3 UPS Supply Chain Solutions Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 DSV
14.7.1 DSV Company Profile
14.7.2 DSV Biopharmaceutical Third Party Logistics Product Specification
14.7.3 DSV Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Sinotrans
14.8.1 Sinotrans Company Profile
14.8.2 Sinotrans Biopharmaceutical Third Party Logistics Product Specification
14.8.3 Sinotrans Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 CEVA Logistics
14.9.1 CEVA Logistics Company Profile
14.9.2 CEVA Logistics Biopharmaceutical Third Party Logistics Product Specification
14.9.3 CEVA Logistics Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Expeditors International of Washington
14.10.1 Expeditors International of Washington Company Profile
14.10.2 Expeditors International of Washington Biopharmaceutical Third Party Logistics Product Specification
14.10.3 Expeditors International of Washington Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Dachser
14.11.1 Dachser Company Profile
14.11.2 Dachser Biopharmaceutical Third Party Logistics Product Specification
14.11.3 Dachser Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Panalpina
14.12.1 Panalpina Company Profile
14.12.2 Panalpina Biopharmaceutical Third Party Logistics Product Specification
14.12.3 Panalpina Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 GEODIS
14.13.1 GEODIS Company Profile
14.13.2 GEODIS Biopharmaceutical Third Party Logistics Product Specification
14.13.3 GEODIS Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Toll Holdings
14.14.1 Toll Holdings Company Profile
14.14.2 Toll Holdings Biopharmaceutical Third Party Logistics Product Specification
14.14.3 Toll Holdings Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 J.B. Hunt (JBI, DCS & ICS)
14.15.1 J.B. Hunt (JBI, DCS & ICS) Company Profile
14.15.2 J.B. Hunt (JBI, DCS & ICS) Biopharmaceutical Third Party Logistics Product Specification
14.15.3 J.B. Hunt (JBI, DCS & ICS) Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Hitachi Transport System
14.16.1 Hitachi Transport System Company Profile
14.16.2 Hitachi Transport System Biopharmaceutical Third Party Logistics Product Specification
14.16.3 Hitachi Transport System Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 XPO Logistics
14.17.1 XPO Logistics Company Profile
14.17.2 XPO Logistics Biopharmaceutical Third Party Logistics Product Specification
14.17.3 XPO Logistics Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 GEFCO
14.18.1 GEFCO Company Profile
14.18.2 GEFCO Biopharmaceutical Third Party Logistics Product Specification
14.18.3 GEFCO Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Yusen Logistics
14.19.1 Yusen Logistics Company Profile
14.19.2 Yusen Logistics Biopharmaceutical Third Party Logistics Product Specification
14.19.3 Yusen Logistics Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Agility
14.20.1 Agility Company Profile
14.20.2 Agility Biopharmaceutical Third Party Logistics Product Specification
14.20.3 Agility Biopharmaceutical Third Party Logistics Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Biopharmaceutical Third Party Logistics Market Forecast (2022-2027)
15.1 Global Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Biopharmaceutical Third Party Logistics Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Biopharmaceutical Third Party Logistics Value and Growth Rate Forecast (2022-2027)
15.2 Global Biopharmaceutical Third Party Logistics Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Biopharmaceutical Third Party Logistics Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Biopharmaceutical Third Party Logistics Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Biopharmaceutical Third Party Logistics Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Biopharmaceutical Third Party Logistics Consumption Forecast by Type (2022-2027)
15.3.2 Global Biopharmaceutical Third Party Logistics Revenue Forecast by Type (2022-2027)
15.3.3 Global Biopharmaceutical Third Party Logistics Price Forecast by Type (2022-2027)
15.4 Global Biopharmaceutical Third Party Logistics Consumption Volume Forecast by Application (2022-2027)
15.5 Biopharmaceutical Third Party Logistics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
